Hollsteen
← Zoom

G&A

Flow – sum over the period · $M

QuartersFiscal years

$MG&A · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.G&A · Q1 FY2019: $8.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019G&A · Q2 FY2019: $10.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019G&A · Q3 FY2019: $12.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019G&A · Q4 FY2019: $15.0M · derived · 10-K 0001585521-20-000095 filed Mar 20, 2020G&A · Q1 FY2020: $19.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019G&A · Q2 FY2020: $21.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019G&A · Q3 FY2020: $24.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019G&A · Q4 FY2020: $24.0M · derived · 10-K 0001585521-21-000048 filed Mar 18, 2021G&A · Q1 FY2021: $53.0M · 10-Q 0001585521-20-000154 filed Jun 5, 2020G&A · Q2 FY2021: $81.0M · 10-Q 0001585521-20-000238 filed Sep 3, 2020G&A · Q3 FY2021: $93.0M · 10-Q 0001585521-20-000299 filed Dec 4, 2020G&A · Q4 FY2021: $93.0M · derived · 10-K 0001585521-22-000037 filed Mar 7, 2022G&A · Q1 FY2022: $154M · 10-Q 0001585521-21-000131 filed Jun 2, 2021G&A · Q2 FY2022: $112M · 10-Q 0001585521-21-000235 filed Aug 31, 2021G&A · Q3 FY2022: $97.0M · 10-Q 0001585521-21-000295 filed Nov 23, 2021G&A · Q4 FY2022: $120M · derived · 10-K 0001585521-23-000035 filed Mar 3, 2023G&A · Q1 FY2023: $118M · 10-Q 0001585521-22-000106 filed May 25, 2022G&A · Q2 FY2023: $131M · 10-Q 0001585521-22-000180 filed Aug 24, 2022G&A · Q3 FY2023: $141M · 10-Q 0001585521-22-000213 filed Nov 23, 2022G&A · Q4 FY2023: $186M · derived · 10-K 0001585521-24-000030 filed Mar 4, 2024G&A · Q1 FY2024: $200M · 10-Q 0001585521-23-000128 filed May 25, 2023G&A · Q2 FY2024: $129M · 10-Q 0001585521-23-000194 filed Aug 23, 2023G&A · Q3 FY2024: $125M · 10-Q 0001585521-23-000249 filed Nov 21, 2023G&A · Q4 FY2024: $125M · derived · 10-K 0001585521-25-000042 filed Feb 28, 2025G&A · Q1 FY2025: $111M · 10-Q 0001585521-24-000094 filed May 22, 2024G&A · Q2 FY2025: $110M · 10-Q 0001585521-24-000181 filed Aug 23, 2024G&A · Q3 FY2025: $126M · 10-Q 0001585521-24-000260 filed Nov 26, 2024G&A · Q4 FY2025: $96.0M · derived · 10-K 0001585521-26-000030 filed Feb 27, 2026G&A · Q1 FY2026: $102M · 10-Q 0001585521-25-000090 filed May 23, 2025G&A · Q2 FY2026: $77.0M · 10-Q 0001585521-25-000141 filed Aug 22, 2025G&A · Q3 FY2026: $95.0M · 10-Q 0001585521-25-000202 filed Nov 25, 2025G&A · Q4 FY2026: $119M · derived · 10-K 0001585521-26-000030 filed Feb 27, 2026G&A · Q1 FY2027: $96.0M · 10-Q 0001585521-26-000071 filed May 22, 2026G&A · Q2 FY2027: $98.0M · 10-Q 0001585521-26-000121 filed Aug 26, 2026missing109.598.27.6199.9Q1 FY2016Q2 FY2027Q2 FY2025
$MG&A · Q2 FY2024: $129M · 10-Q 0001585521-23-000194 filed Aug 23, 2023G&A · Q3 FY2024: $125M · 10-Q 0001585521-23-000249 filed Nov 21, 2023G&A · Q4 FY2024: $125M · derived · 10-K 0001585521-25-000042 filed Feb 28, 2025G&A · Q1 FY2025: $111M · 10-Q 0001585521-24-000094 filed May 22, 2024G&A · Q2 FY2025: $110M · 10-Q 0001585521-24-000181 filed Aug 23, 2024G&A · Q3 FY2025: $126M · 10-Q 0001585521-24-000260 filed Nov 26, 2024G&A · Q4 FY2025: $96.0M · derived · 10-K 0001585521-26-000030 filed Feb 27, 2026G&A · Q1 FY2026: $102M · 10-Q 0001585521-25-000090 filed May 23, 2025109.5102.3129.3Q2 FY2024Q1 FY2026Q2 FY2025
Q2 FY2025
109.5$M
All values (34)
PeriodValue ($M)Status
Q2 FY202798.2reported
Q1 FY202796.3reported
Q4 FY2026119.0derived
Q3 FY202694.7reported
Q2 FY202676.9reported
Q1 FY2026102.3reported
Q4 FY202595.7derived
Q3 FY2025126.1reported
Q2 FY2025109.5reported
Q1 FY2025111.3reported
Q4 FY2024125.3derived
Q3 FY2024125.1reported
Q2 FY2024129.3reported
Q1 FY2024199.9reported
Q4 FY2023186.5derived
Q3 FY2023141.0reported
Q2 FY2023131.1reported
Q1 FY2023117.8reported
Q4 FY2022119.8derived
Q3 FY202296.7reported
Q2 FY2022112.1reported
Q1 FY2022154.1reported
Q4 FY202192.7derived
Q3 FY202193.5reported
Q2 FY202181.2reported
Q1 FY202153.1reported
Q4 FY202023.6derived
Q3 FY202023.8reported
Q2 FY202021.0reported
Q1 FY202018.5reported
Q4 FY201914.9derived
Q3 FY201912.0reported
Q2 FY201910.0reported
Q1 FY20197.6reported
Q1 FY2016 – Q4 FY2018–missing (12 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: ga

More metrics for Zoom

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$110M
Period
Q2 FY2025, ended Jul 31, 2024 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 23, 2024 · 0001585521-24-000181
Location
us-gaap:GeneralAndAdministrativeExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$110MAug 23, 202410-Q 0001585521-24-000181reported · confidence 1. · current